Stemtech Corp (STEK) stock

STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30

$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $296.22KP/E –Yield –

Stemtech EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Stemtech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is STEK.

Revenue growth-50.9% · median -27.4%

Gross margin75.7% · median 46.2%

Operating margin-134.0% · median -74.3%

Net margin-191.3% · median -327.3%

Advertisement
300 × 250

See a number that looks wrong?